South Korea Beefs Up Infrastructure To Lead Asia In Early-Stage Clinical Trials

SEOUL - South Korea is drawing more Phase I and Phase II clinical trials from its former foothold in Phase III and post-approval trials, Korea National Enterprise for Clinical Trials reported